Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics

cafead

Administrator
Staff member
  • cafead   Jun 20, 2023 at 11:42: AM
via Eli Lilly has taken a high-stakes gamble on oral IL-17 inhibitors, betting $2.4 billion upfront that acquiring Dice Therapeutics will expand its autoimmune arsenal.

article source